164 related articles for article (PubMed ID: 30205135)
21. Apigenin induces apoptosis through proteasomal degradation of HER2/neu in HER2/neu-overexpressing breast cancer cells via the phosphatidylinositol 3-kinase/Akt-dependent pathway.
Way TD; Kao MC; Lin JK
J Biol Chem; 2004 Feb; 279(6):4479-89. PubMed ID: 14602723
[TBL] [Abstract][Full Text] [Related]
22. The mTOR inhibitor rapamycin synergizes with a fatty acid synthase inhibitor to induce cytotoxicity in ER/HER2-positive breast cancer cells.
Yan C; Wei H; Minjuan Z; Yan X; Jingyue Y; Wenchao L; Sheng H
PLoS One; 2014; 9(5):e97697. PubMed ID: 24866893
[TBL] [Abstract][Full Text] [Related]
23. Down-regulation of PKM2 decreases FASN expression in bladder cancer cells through AKT/mTOR/SREBP-1c axis.
Tao T; Su Q; Xu S; Deng J; Zhou S; Zhuang Y; Huang Y; He C; He S; Peng M; Hocher B; Yang X
J Cell Physiol; 2019 Mar; 234(3):3088-3104. PubMed ID: 30221356
[TBL] [Abstract][Full Text] [Related]
24. Kahweol Induces Apoptosis in Hepatocellular Carcinoma Cells by Inhibiting the Src/mTOR/STAT3 Signaling Pathway.
Seo HY; Lee SH; Lee JH; Lee JH; Jang BK; Kim MK
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638852
[TBL] [Abstract][Full Text] [Related]
25. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
[TBL] [Abstract][Full Text] [Related]
26. Novel Hsp90 inhibitor FW-04-806 displays potent antitumor effects in HER2-positive breast cancer cells as a single agent or in combination with lapatinib.
Huang W; Wu QD; Zhang M; Kong YL; Cao PR; Zheng W; Xu JH; Ye M
Cancer Lett; 2015 Jan; 356(2 Pt B):862-71. PubMed ID: 25449780
[TBL] [Abstract][Full Text] [Related]
27. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
Asanuma H; Torigoe T; Kamiguchi K; Hirohashi Y; Ohmura T; Hirata K; Sato M; Sato N
Cancer Res; 2005 Dec; 65(23):11018-25. PubMed ID: 16322251
[TBL] [Abstract][Full Text] [Related]
28. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway.
Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811
[TBL] [Abstract][Full Text] [Related]
29. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
Tseng PH; Wang YC; Weng SC; Weng JR; Chen CS; Brueggemeier RW; Shapiro CL; Chen CY; Dunn SE; Pollak M; Chen CS
Mol Pharmacol; 2006 Nov; 70(5):1534-41. PubMed ID: 16887935
[TBL] [Abstract][Full Text] [Related]
30. Osthole suppresses fatty acid synthase expression in HER2-overexpressing breast cancer cells through modulating Akt/mTOR pathway.
Lin VC; Chou CH; Lin YC; Lin JN; Yu CC; Tang CH; Lin HY; Way TD
J Agric Food Chem; 2010 Apr; 58(8):4786-93. PubMed ID: 20218616
[TBL] [Abstract][Full Text] [Related]
31. Kahweol blocks STAT3 phosphorylation and induces apoptosis in human lung adenocarcinoma A549 cells.
Kim HG; Hwang YP; Jeong HG
Toxicol Lett; 2009 May; 187(1):28-34. PubMed ID: 19429240
[TBL] [Abstract][Full Text] [Related]
32. Triticuside A, a dietary flavonoid, inhibits proliferation of human breast cancer cells via inducing apoptosis.
Shan Y; Cheng Y; Zhang Y; Guan FQ; Sun H; Ren XC; Chen Y; Feng X; Yang JM
Nutr Cancer; 2013; 65(6):891-9. PubMed ID: 23909734
[TBL] [Abstract][Full Text] [Related]
33. Post-transcriptional regulation of chemokine receptor CXCR4 by estrogen in HER2 overexpressing, estrogen receptor-positive breast cancer cells.
Sengupta S; Schiff R; Katzenellenbogen BS
Breast Cancer Res Treat; 2009 Sep; 117(2):243-51. PubMed ID: 18807177
[TBL] [Abstract][Full Text] [Related]
34. Flaxseed oil enhances the effectiveness of trastuzumab in reducing the growth of HER2-overexpressing human breast tumors (BT-474).
Mason JK; Fu M; Chen J; Thompson LU
J Nutr Biochem; 2015 Jan; 26(1):16-23. PubMed ID: 25441844
[TBL] [Abstract][Full Text] [Related]
35. Herceptin-induced inhibition of phosphatidylinositol-3 kinase and Akt Is required for antibody-mediated effects on p27, cyclin D1, and antitumor action.
Yakes FM; Chinratanalab W; Ritter CA; King W; Seelig S; Arteaga CL
Cancer Res; 2002 Jul; 62(14):4132-41. PubMed ID: 12124352
[TBL] [Abstract][Full Text] [Related]
36. Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells.
Do MT; Kim HG; Choi JH; Khanal T; Park BH; Tran TP; Jeong TC; Jeong HG
Food Chem; 2013 Dec; 141(3):2591-9. PubMed ID: 23870999
[TBL] [Abstract][Full Text] [Related]
37. Gold nanoparticles-conjugated quercetin induces apoptosis via inhibition of EGFR/PI3K/Akt-mediated pathway in breast cancer cell lines (MCF-7 and MDA-MB-231).
Balakrishnan S; Mukherjee S; Das S; Bhat FA; Raja Singh P; Patra CR; Arunakaran J
Cell Biochem Funct; 2017 Jun; 35(4):217-231. PubMed ID: 28498520
[TBL] [Abstract][Full Text] [Related]
38. Leucine deprivation inhibits proliferation and induces apoptosis of human breast cancer cells via fatty acid synthase.
Xiao F; Wang C; Yin H; Yu J; Chen S; Fang J; Guo F
Oncotarget; 2016 Sep; 7(39):63679-63689. PubMed ID: 27579768
[TBL] [Abstract][Full Text] [Related]
39. PTK6 inhibition promotes apoptosis of Lapatinib-resistant Her2(+) breast cancer cells by inducing Bim.
Park SH; Ito K; Olcott W; Katsyv I; Halstead-Nussloch G; Irie HY
Breast Cancer Res; 2015 Jun; 17(1):86. PubMed ID: 26084280
[TBL] [Abstract][Full Text] [Related]
40. Kahweol induces apoptosis by suppressing BTF3 expression through the ERK signaling pathway in non-small cell lung cancer cells.
Jeon YJ; Bang W; Cho JH; Lee RH; Kim SH; Kim MS; Park SM; Shin JC; Chung HJ; Oh KB; Seo JM; Ko S; Shim JH; Chae JI
Int J Oncol; 2016 Dec; 49(6):2294-2302. PubMed ID: 27748804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]